| (Values in U.S. Thousands) | May, 2022 | May, 2021 | May, 2020 | May, 2019 | May, 2018 |
| Sales | 293 | 0 | 133 | 240 | 27 |
| Sales Growth | unch | -100.00% | -44.44% | +799.99% | unch |
| Net Income | -3,689 | -4,420 | -2,607 | -2,459 | -2,408 |
| Net Income Growth | +16.53% | -69.52% | -6.05% | -2.08% | -1,220.06% |
Canntab Therapeutics Ltd (PILL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of pharmaceutical-grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use.
Fiscal Year End Date: 05/31